Sosnovoborsk, Russia

Ludmila Burakova

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Axxam S.p.a., Bayer Schering Pharma Aktiengsellschaft. Active years: 2010-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ludmila Burakova. Retrieved from https://idiyas.com/inventor/ludmila-burakova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2010-2011

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ludmila Burakova: Innovator in Fluorescent Proteins

Introduction

Ludmila Burakova is a notable inventor based in Sosnovoborsk, Russia. She has made significant contributions to the field of biotechnology, particularly in the development of fluorescent proteins. With a total of 2 patents, her work has implications for various scientific applications.

Latest Patents

Burakova's latest patents include inventions related to nucleotide and amino acid sequences, as well as the activity and use of the fluorescent protein CGFP. Additionally, she has developed the photoprotein mtClytin, which encompasses its nucleotide and amino acid sequences and its various applications.

Career Highlights

Throughout her career, Burakova has worked with prominent companies such as Bayer Schering Pharma Aktiengesellschaft and Axxam S.p.a. Her experience in these organizations has allowed her to refine her expertise in biotechnology and innovation.

Collaborations

Some of her notable coworkers include Stefan Golz and Svetlana Markova. Their collaborative efforts have contributed to the advancement of research in the field.

Conclusion

Ludmila Burakova's innovative work in fluorescent proteins and her contributions to biotechnology highlight her as a significant figure in her field. Her patents and collaborations reflect her dedication to advancing scientific knowledge and applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…